How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Implanted Monitoring Devices Market
- By Device Type: Cardiac Implantable Electronic Devices (CIEDs), Neurostimulators, Implantable Glucose Monitors, Implantable Pressure Sensors, Implantable Drug Delivery Systems
- By Application: Cardiovascular Monitoring, Neurological Monitoring, Diabetes Management, Respiratory Monitoring, Oncology Monitoring
- By End User: Hospitals, Specialty Clinics, Home Healthcare Settings, Research Institutions
- By Technology: Wireless Telemetry, Battery-Powered Devices, Energy Harvesting Devices, Bio-compatible Sensors
- By Implantation Duration: Temporary Implants, Long-term Implants, Permanent Implants
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Cardiac Implantable Electronic Devices (CIEDs) leads By Device Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Implanted Monitoring Devices Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Device Type 5
Application 5
End User 4
Technology 4
Implantation Duration 3
Companies profiled
Medtronic
Abbott Laboratories
Boston Scientific
BIOTRONIK
Stryker Corporation
Philips Healthcare
GE Healthcare
Johnson & Johnson (Biosense Webster)
ResMed
Dexcom
Insulet Corporation
Natus Medical Incorporated
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Medtronic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Abbott Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Boston Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →BIOTRONIK
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →GE Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Johnson & Johnson (Biosense Webster)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →ResMed
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Dexcom
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Insulet Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Natus Medical Incorporated
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Edwards Lifesciences
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Proteus Digital Health
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →AliveCor
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,028M by 2033 · 4.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Cardiac Implantable Electronic Devices (CIEDs)43.1
- Neurostimulators11.3
- Implantable Glucose Monitors12.9
- Implantable Pressure Sensors11.4
- Implantable Drug Delivery Systems21.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,201M → $1,671M · 4.2%
Europe$837.2M → $1,144M · 4.0%
Asia Pacific$764.4M → $990.9M · 3.3%
Latin America$473.2M → $648.0M · 4.0%
Middle East and Africa$364.0M → $520.9M · 4.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.082026
4.082027
4.092028
4.122029
4.122030
4.132031
4.152032
4.162033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Medtronic22.7
- Abbott Laboratories11.4
- Boston Scientific6.8
- BIOTRONIK11.1
- Stryker Corporation8.8
- Philips Healthcare11.2
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Device Type31.7%
Application24.3%
End User15.6%
Technology13.3%
Implantation Duration15.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.6
- Europe23.0
- Asia Pacific19.9
- Latin America13.0
- Middle East and Africa10.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Medtronic | 90 | 81 | 78 | 84 | 84 | 97 | 86 |
| Abbott Laboratories | 71 | 87 | 85 | 86 | 92 | 87 | 85 |
| Boston Scientific | 67 | 64 | 80 | 81 | 79 | 70 | 74 |
| BIOTRONIK | 59 | 71 | 57 | 77 | 74 | 65 | 67 |
| Stryker Corporation | 56 | 51 | 68 | 65 | 54 | 67 | 60 |
| Philips Healthcare | 57 | 53 | 50 | 50 | 47 | 63 | 53 |
| GE Healthcare | 47 | 64 | 54 | 41 | 59 | 40 | 51 |
| Johnson & Johnson (Biosense Webster) | 45 | 41 | 35 | 57 | 38 | 57 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Medtronic
- Abbott Laboratories
- Boston Scientific
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Medtronic | ◐ | ✓ | ◐ | ◐ | ✓ | ✓ |
| Abbott Laboratories | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Boston Scientific | ✓ | ◐ | ◐ | ◐ | ◐ | ◐ |
| BIOTRONIK | ◐ | ◐ | − | ◐ | ✓ | ◐ |
| Stryker Corporation | − | − | − | ◐ | ◐ | ◐ |
| Philips Healthcare | ◐ | ◐ | − | − | − | ◐ |
| GE Healthcare | − | ◐ | − | − | ◐ | − |
| Johnson & Johnson (Biosense Webster) | ◐ | − | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Medtronic86
2Abbott Laboratories85
3Boston Scientific74
4BIOTRONIK67
5Stryker Corporation60
6Philips Healthcare53
7GE Healthcare51
8Johnson & Johnson (Biosense Webster)46
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
MedtronicAbbott Laboratories
Challenger2
Strong scale, closing on the leaders.
Boston ScientificBIOTRONIK
Contender1
Focused players with pockets of strength.
Stryker Corporation
Niche3
Specialists in a single segment or region.
Philips HealthcareGE HealthcareJohnson & Johnson (Biosense Webster)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Device Type in North America, then scale across Implanted Monitoring Devices Market — a $224M beachhead inside a $4.12B market.
Beachhead (SOM)$224Mobtainable near-term
Serviceable (SAM)$1.57Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Cardiac Implantable Electronic Devices (CIEDs)
Best fit — highest urgency & budget in Device Type.
Economic buyer77 fit
Neurostimulators
Strong fit — clear ROI and a fast path to value.
End user67 fit
Implantable Glucose Monitors
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Device Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales47%
Partner / channel28%
Digital / self-serve19%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Device Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Implanted Monitoring Devices Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified25%
Evaluation12%
Closed-won5%
$21.9KCAC
$125KLTV
5.7:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Implanted Monitoring Devices Market is a durable-growth opportunity — $7.45B by 2033, compounding at 9.2%.
TAM · 2025$3.69Btoday
TAM · 2033$7.45Bforecast
CAGR9.2%2027–2033
Cumulative$48.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.45BTotal addressable market
SAM$3.03BServiceable available market
SOM$581MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.2% CAGR
Demand compounds through 2033, outpacing GDP across Device Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Device Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.45BLarge & growingTAM by 2033 at 9.2% CAGR
$3.03BServiceable nowreachable with today’s model
$581MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.81BBear6.0% CAGR
$7.45BBase9.2% CAGR
$9.53BBull12.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Implanted Monitoring Devices Market — a $2.08B market by 2033. Plan: grow share from 6.9% to 14.2%.
Market size · 2033$2.08Btotal addressable
Market CAGR11.2%2027–2033
Target share14.2%from 6.9% today
Revenue ambition$295Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.9% | 14.2% | Behind |
| Revenue | $155M | $295M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 36.3% | 39.1% | Behind |
| Customer retention | 89.4% | 93.4% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Device Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Device Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $32M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Device Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAhead
- Input-cost & supply riskBehind
- Regulatory / policy changeBehind
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Implanted Monitoring Devices Market conversation — a $8.11B market you can size, segment and defend in minutes.
Market size · 2033$8.11Btotal opportunity
Growth9.4%CAGR to 2033
Addressable buyers1,793+accounts in scope
Typical ROI7.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Device Type
Goal Grow share in Device Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.4×return on cost, year one
< 3 mopayback period
$85K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
MedtronicAbbott LaboratoriesBoston ScientificBIOTRONIKStryker CorporationPhilips HealthcareGE HealthcareJohnson & Johnson (Biosense Webster)+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Implanted Monitoring Devices Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Implanted Monitoring Devices Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Implantology Contra-Angle Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportImplants & Interventional Materials Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportImplement Guidance System Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportImplement Steering System Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportImp-Na Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportImported Cosmetics Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportImported Fresh or Chilled Cucumbers and Gherkins Industry 2017 Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportImported WallpaperController Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportImports Brake Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportImpregnated Graphite Electrodes Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportImpregnated With Phenolic Resin Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportImpregnating Insulating Varnish Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.